24.01.2023 12:58:53
|
GE Turns To Profit In Q4, Beats Market; Sees Growth In FY23; Stock Up In Pre Market
(RTTNews) - Industrial conglomerate General Electric Co. (GE) reported Tuesday a profit in its fourth quarter, above market estimates, compared to last year's loss, benefited by higher revenues. Looking ahead, the company projects higher adjusted earnings and organic revenues in fiscal 2023.
In pre-market activity on the NYSE, GE shares were gaining around 3 percent to trade at $81.84.
The results included the operations of GE HealthCare Technologies Inc., which was separated in early January in a spin-off.
In the fourth quarter, net earnings attributable to GE shareholders were $2.13 billion, compared to last year's loss of $3.90 billion. Earnings per share were $1.93, compared to loss of $3.55 a year ago.
Continuing earnings per share were $1.99, while prior year's loss was $3.24 per share.
In the quarter, adjusted earnings per share were $1.24, compared to $0.82 last year.
On average, 17 analysts polled by Thomson Reuters expected earnings of $1.13 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues grew 7 percent to $21.79 billion from prior year's $20.30 billion. Organic revenues grew 11 percent. Analysts estimated revenues of $21.59 billion for the quarter.
For fiscal 2023, GE, excluding GE HealthCare, expects adjusted earnings per share of $1.60 to $2.00 on organic revenue growth in high single digits from the previous year.
In fiscal 2022, GE's loss excluding GE HealthCare on a reported basis was $1.11 per share, and adjusted earnings were $0.77 per share. Revenue growth was 3 percent on a reported basis, and 6 percent organically.
Including GE HealthCare, the prior year's net loss was $0.05 per share, continuing earnings were $0.53 per share, and adjusted earnings were $2.62 per share, on total revenues of $76.56 billion.
In fiscal 2023, GE Aerospace expects organic revenue to grow mid-to-high teens, with operating profit of $5.3 billion to $5.7 billion.
GE Vernova expects organic revenue to grow low-to-mid single digits, with operating loss of $0.6 billion to $0.2 billion.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu GE HealthCare Technologiesmehr Nachrichten
06.12.24 |
S&P 500-Papier GE HealthCare Technologies-Aktie: So viel Gewinn hätte ein GE HealthCare Technologies-Investment von vor einem Jahr eingefahren (finanzen.at) | |
21.11.24 |
S&P 500 aktuell: S&P 500 schließt im Plus (finanzen.at) | |
21.11.24 |
Gewinne in New York: S&P 500 nachmittags fester (finanzen.at) | |
21.11.24 |
Pluszeichen in New York: So bewegt sich der S&P 500 am Mittag (finanzen.at) | |
08.11.24 |
S&P 500-Papier GE HealthCare Technologies-Aktie: So viel hätte eine Investition in GE HealthCare Technologies von vor einem Jahr abgeworfen (finanzen.at) | |
29.10.24 |
Ausblick: GE HealthCare Technologies verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
28.10.24 |
Starker Wochentag in New York: S&P 500-Börsianer greifen am Montagnachmittag zu (finanzen.at) | |
28.10.24 |
Handel in New York: Das macht der S&P 500 am Montagmittag (finanzen.at) |
Analysen zu GE HealthCare Technologiesmehr Analysen
Aktien in diesem Artikel
GE Aerospace (ex General Electric) | 164,50 | 1,54% | |
GE HealthCare Technologies | 76,03 | 0,97% |